News

Genetic mapping reveals early mutations in stomach cancer development
Researchers from the Department of Pathology, School of Clinical Medicine at the LKS Faculty of Medicine of the University of ...
Science Daily5d
Early mutations and risk factors for stomach cancer, and develops a pre-cancer model for stomach cancer prevention
Researchers have made significant advancements in understanding the earliest stages of stomach cancer, a leading cause of cancer-related deaths worldwide, through two recent innovative studies. With a ...
EurekAlert!6d
HKUMed uncovers early mutations and risk factors for stomach cancer, and develops a pre-cancer model for stomach cancer prevention
Researchers from the Department of Pathology, School of Clinical Medicine at the LKS Faculty of Medicine of the University of ...
Medical Dialogues7d
Helicobacter pylori eradication helps prevent gastric cancer in elderly: Study
A new study published in the journal of Gastroenterology showed that even in individuals 70 and older, eliminating ...
Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...
EL PAÍS English11d
Paul Mischel, discoverer of a new cause of cancer: ‘It will be possible to cure it in many people’
The American doctor has revealed that enigmatic DNA circles are present in more than half of patients with highly aggressive ...
Business Insider29d
Philips and Ibex expand partnership to enhance AI-enabled pathology workflows for better patient care
breast and gastric cancer diagnostics. Expanding access and streamlining the use of AI-powered tools in digital pathology will further enhance the efficiency and effectiveness of pathology labs.
Healio13d
Biomarker testing underutilized in gastric, gastroesophageal junction cancers
Less than one-quarter of oncologists surveyed indicated that every one of their patients with advanced gastric or gastroesophageal junction cancers received biomarker testing consistent with practice ...